Executive Committee: Scilex Holding Company

Manager
Positions heldSince
Jaisim Shah

Jaisim Shah

63 year

Chief Executive Officer 2022-11-08
President 2022-11-08
Suketu D. Desai

Suketu D. Desai

59 year

Chief Tech/Sci/R&D Officer -
Dmitri V. Lissin

Dmitri V. Lissin

55 year

Chief Tech/Sci/R&D Officer -
Stephen Ma

Stephen Ma

51 year

Director of Finance/CFO 2023-09-21
Investor Relations Contact 2021-12-31
Public Communications Contact 2021-12-31
Corporate Secretary 2024-03-05
Steve Lincoln

Steve Lincoln

Compliance Officer -
General Counsel -
Sumant Rajendran

Sumant Rajendran

Sales & Marketing -

Composition of the Board of Directors: Scilex Holding Company

Director
CommitteesSince
Henry Ji

Henry Ji

59 year

Chairman 2022-11-08
Yue Wu

Yue Wu

62 year

Audit Committee 2023-09-21
Compensation Committee Chair 2023-03-20
Compensation Committee 2023-09-21
Governance Committee 2023-09-21
Nominating Committee 2023-09-21
Dorman Followwill

Dorman Followwill

60 year

Audit Committee 2022-11-08
Compensation Committee 2017-09-30
Governance Committee Chair 2022-11-08
Nominating Committee Chair 2022-11-08
Compensation Committee Chair
David Lemus

David Lemus

61 year

Audit Committee Chair 2022-11-08
Compensation Committee 2018-06-20
Annu Navani

Annu Navani

54 year

Director/Board Member 2024-07-20
Jay Chun

Jay Chun

60 year

Director/Board Member 2023-09-21
Independent Dir/Board Member 2023-09-21
Jaisim Shah

Jaisim Shah

63 year

Director/Board Member 2022-11-08

Former Officers and Directors: Scilex Holding Company

Insider
Positions held
SinceUntil
Laura Hamill
Laura Hamill
Director/Board Member 2022-11-08 2023-09-20
Independent Dir/Board Member 2022-11-08 2023-09-20
Elizabeth Czerepak
Elizabeth Czerepak
Comptroller/Controller/Auditor 2022-11-09 2023-09-19
Director/Board Member - 2022-11-09
Director of Finance/CFO 2022-11-09 2023-09-19
Corporate Secretary 2022-11-09 2023-09-19
Tien-Li Lee
Tien-Li Lee
Director/Board Member 2022-11-08 2023-08-26
Independent Dir/Board Member 2022-11-08 2023-08-26
Tommy Thompson
Tommy Thompson
Director/Board Member 2022-11-08 2023-04-05
Independent Dir/Board Member 2022-11-08 2023-04-05

Age distribution of managers

Parity Men Women

Male 13
Female 0

Of which Executive Committee

Male 6
Female 0

Of which Directors

Male 7
Female 0
ESG Refinitiv
-
Logo Scilex Holding Company
Scilex Holding Company is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system) 1.8%, is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It also focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. Its second commercial product ELYXYB, is a potential first-line treatment, ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults. Its product candidates include SP-102 (SEMDEXA), SP-103 and SP-104. SP-102 is a viscous gel formulation of a used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica. Its SP-103 is a triple-strength formulation of ZTlido, for the treatment of chronic neck pain.
Employees
113
More about the company
-40% Exceptional Extension: Our subscriptions help you unlock hidden opportunities. Exceptional extension!
BENEFIT NOW